Today is Clinical Trials Day – a moment to say a huge thank you to the incredible research participants across the country and the dedicated research teams who make it all possible.
🧵 (1/3)
Delighted to present the final report for our DIPLOMA evaluation of the NHS Diabetes Prevention Programme. A true team effort - thanks to everyone who helped along the way
TL;DR prevention at scale is viable, with plenty of scope for optimising further
https://t.co/UJOqF2FONj
Are you a pregnant/breastfeeding Black, Asian or Arabic mother? Researchers looking at low levels of vitamin D in pregnancy have a workshop at Kings House Conference Centre, Manchester 17 January, 11-3:30pm with refreshment breaks. Email [email protected]
Last few weeks to take part in this unique study. A tribute to @Dr_Sudeh a dear friend and wonderful colleague we will remember forever @PrimaryCareMcr
Last few weeks to take part in this unique study. A tribute to @Dr_Sudeh a dear friend and wonderful colleague we will remember forever @PrimaryCareMcr
To support more ethnically diverse trials:
'Funders need to clearly signal to trial teams that the time and costs needed for greater ethnic diversity are not only accepted but also expected.'
https://t.co/WfDmRko8Jr
A new Trial Forge paper is out today:
How should trial teams make decisions about the proportions and diversity of the ethnic groups in their trial?
https://t.co/4ZmT0vtkdO
#inclusion
Co-produced projects are a rewarding, messy rollercoaster of a journey!
Our new paper shares reflections on practicalities, learning and challenges throughout the co-production journey of InCLUDE, based on our personal reflective diaries.
https://t.co/kapeRu1HKP
After months of speaking with professionals in trials, a key takeaway: intersectionality is poorly understood and hard to implement. While inclusion is vital, we need simpler, practical ways to apply intersectionality in trials. More insights to come! #ICTMC2024#ClinicalTrials
Does belonging to multiple disadvantaged groups = worse health? 🤔 My review shows that it does. This is why clinical trials must address intersectionality if we are to properly tackle health inequalities. #ICTMC2024#PhD#ClinicalTrials#Intersectionality
Discussion in the retention and follow up session on why we don't capture experiences of people who stay in trials. @Bowercpcman led the development of this measure for exactly that. Now let's think about implementation of said measure https://t.co/wvG5nsjDUg #ICTMC2024
Also from the @ictmc2024 workshop on inclusion, the the STEP UP guidance to help researchers design inclusive clinical trials, in press but pre-print at:
https://t.co/NumyTEAdmn
#ICTMC2024
Great conference to share work - including opportunities to try out your emerging analysis ideas with a great audience. Get writing your abstract! @sapcacuk
Want to know more about what makes a good core outcome set research study invitation for patients and the public? If you missed it today, catch our pdf poster on the @ictmc2024 app. @COMETinitiative
One week to go! Final call for people to complete our survey. We want to know what people think about clinic letters written by #Rheumatology healthcare professionals. You do not need to have received a clinic letter to take part. Survey closing at 09:00 on Friday, 27 September.
🔴 We've gone #Red4Research today to show our gratitude for all those who make research possible. Join us by posting a photo of yourself in red to show your support! 🔴